End-stage lung diseases may result in death either by oxygenation and carbon dioxide exchange insufficiency or by right heart failure. Despite recent dramatic improvements in the medical management of these diseases, lung transplantation remains ultimately the only therapeutic option. However, shortage of donor organs and long waiting times on list make this treatment only available for few patients.

more information : postdoc_bioartlung